Cargando…
Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial
BACKGROUND: Antidepressants are established as an evidence-based, guideline-recommended treatment for Major Depressive Disorder. Prescriptions have markedly increased in past decades, with a specific surge in maintenance prescribing. Patients often remain on antidepressants longer than clinically ne...
Autores principales: | Meißner, Carina, Warren, Claire, Fadai, Tahmine, Müller, Amke, Zapf, Antonia, Lezius, Susanne, Ozga, Ann-Kathrin, Falkenberg, Irina, Kircher, Tilo, Nestoriuc, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286435/ https://www.ncbi.nlm.nih.gov/pubmed/37344789 http://dx.doi.org/10.1186/s12888-023-04941-3 |
Ejemplares similares
-
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
por: Müller, Amke, et al.
Publicado: (2023) -
Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019) -
Predictors of successful discontinuation of antipsychotics and antidepressants
por: Lincoln, Tania M., et al.
Publicado: (2023) -
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
por: Boremalm, Malin, et al.
Publicado: (2021) -
Conversations with clients about antidepressant withdrawal and discontinuation
por: Karter, Justin M.
Publicado: (2020)